RH1

CAS No. 221635-42-3

RH1( —— )

Catalog No. M33479 CAS No. 221635-42-3

RH1 (NSC 697726) is a bioreductive anticancer compound that exhibits dose-dependent biphasic effects in vitro, inducing apoptosis at higher doses and senescence at lower doses.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 424 In Stock
10MG 682 In Stock
25MG 1378 In Stock
50MG 1841 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    RH1
  • Note
    Research use only, not for human use.
  • Brief Description
    RH1 (NSC 697726) is a bioreductive anticancer compound that exhibits dose-dependent biphasic effects in vitro, inducing apoptosis at higher doses and senescence at lower doses.
  • Description
    RH1 (NSC 697726) is a bioreductive anticancer compound that exhibits dose-dependent biphasic effects in vitro, inducing apoptosis at higher doses and senescence at lower doses.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    221635-42-3
  • Formula Weight
    234.25
  • Molecular Formula
    C12H14N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1C(=C(C(=O)C(=C1C)N2CC2)CO)N3CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Gardenoside

    Gardenoside can inhibit the secretion of gastric juice and reduce the role of pancreatic amylase.

  • SF5

    SF5 is an inhibitor of the apoptosis pathway through JNK-p53-caspase apoptotic cascade.

  • PCC0208017

    PCC0208017 is an inhibitor of MARK3 and MARK4 with IC50s of 1.8 and 2.01 nM. PCC0208017 disrupts microtubule dynamics and displays potent antitumor activity.